Search results for: Professor Adrian Towse
Filter search results
New Publications: Optimal Development and Use of Real-World Evidence for Coverage and Formulary Decisions
18 April 2018
…decisions, co-authored by Grace Hampson and Adrian Towse. The publications represent 1) the background paper to the 2017 ICER Membership Policy Summit and 2) a follow-up paper based on the…
Spotlight on OHE: EQ-5D-5L, Next Generation Sequencing, and MCDA
19 December 2014
…An HTA perspective on the implications for drug reimbursement Speaking in Amsterdam on 13th November 2014 Adrian Towse delivered a presentation at the 3rd Annual Health Economics & Personalised…
Bengt Jönsson Honoured for Contribution to Health Economics
6 August 2014
…The chapter contributed by OHE’s Adrian Towse[2] discusses Bengt’s observations in a 2011 publication[3] about the role of relative effectiveness research (RE) in the European medicines market. To ensure value…
Establishing a Reasonable Price for an Orphan Drug
11 September 2020
Berdud, Drummond and Towse (2020) propose a method for establishing a reasonable price for an orphan drug. Assuming prices for drugs are set according to incremental value, they propose adjustments…
Rare Disease Day 2024: Why Do We Care About Rare?
29 February 2024
…patient/carer ability to go to school/work – Towse and Garau argued that it is inappropriate to focus appraisals solely on a cost-per-QALY measure. In recognition of this broad set of…
Is It Time to Reconsider the Role of Co-Payments in Europe?
11 January 2012
In a recent editorial in the European Journal of Health Economics, Prof Michael Drummond of York University and Prof Adrian Towse of the OHE take a new look at an…
Prospective Observational Studies: Whether, When and How to Use
18 June 2012
OHE’s Adrian Towse is co-author on the recent report by the ISPOR Good Research Practices Task Force on assessing comparative effectiveness using prospective observational studies. Prof Towse OHE’s Adrian…
Performance-Based Risk Sharing in Health Care: Current Status
17 April 2013
…explicitly link pricing, reimbursement and/or revenue to what the data show. At the mid-year symposium of the International Society of Pharmacoepidemiology (ISPE), OHE’s Adrian Towse reviewed the challenges such approaches…
Spotlight on OHE: Development and Use of Measures of Health Worldwide
16 July 2012
…Bill and Melinda Gates Foundation. Please see our earlier post for a summary. The application of HTA in emerging markets, specifically Latin America, was the focus of Adrian Towse’s contributions…